Women With Early Breast Cancer to Be Tested for Trastuzumab Treatment

BMJ
doi 10.1136/bmj.331.7521.864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2019English

The Use of Trastuzumab in New Zealand Women With Breast Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Trastuzumab as Adjuvant Treatment for Early Stage HER2-positive Breast Cancer — A 10 Year History

Nowotwory
Cancer ResearchOncology
2017English

All Pregnant Women Should Be Tested for HIV

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study

Oncologist
Cancer ResearchMedicineOncology
2013English

Trastuzumab-Containing Regimens for Metastatic Breast Cancer

Cochrane Database of Systematic Reviews
2014English

Treatment of Early Breast Cancer

The Lancet
Medicine
1978English

Treatment of Early Breast Cancer.

BMJ
1972English

Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy